跳至主要内容
临床试验/NCT04046315
NCT04046315Unknown不适用

Early Detection of Cardiac Damage With CMR in Women With Breast Cancer

Radboud University Medical Center1 个研究点 分布在 1 个国家目标入组 55 人开始时间: 2020年3月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
55
试验地点
1
主要终点
Global Longitudinal Strain (GLS) change after chemotherapy compared to baseline

研究概览

简要总结

With this study the investigators will assess early cardiac damage by means of Global Longitudinal Strain (GLS) in newly diagnosed breast cancer (BC) patients treated with anthracycline-based chemotherapy, and to investigate whether myocardial damage as measured with T1 / T2 Cardiovascular Magnetic Resonance (CMR) mapping and plasma hs-Troponin T is related to changes in GLS.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age ≥ 18 years
  • A diagnosis of primary breast cancer
  • Starting (neo-) adjuvant chemotherapy treatment within 2 months after screening
  • Cardiotoxicity risk score of intermediate, high or very high risk

排除标准

  • Previous radiotherapy or systemic cancer treatment
  • Cancer metastasis
  • Life expectancy of less than 6 months
  • History of myocardial infarction or heart failure
  • Known contra-indications for CMR
  • Refusal or inability to provide informed consent

结局指标

主要结局

Global Longitudinal Strain (GLS) change after chemotherapy compared to baseline

时间窗: Baseline and 2 weeks after the last chemotherapy cycle

A relative reduction in Global Longitudinal Strain (GLS) assessed with CMR

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验